Standard Biotools Inc (LAB) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Standard Biotools Inc   (NASDAQ: LAB)

Standard Biotools Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Standard Biotools Inc in the second quarter 2026?
Standard Biotools Inc achieved a return on average equity (ROE) of 17.64 % in its second quarter 2026 a new company high.

While the company's net income was fading, Standard Biotools Inc was able to improve its ROE compared to the first quarter 2026.

Within the Laboratory Analytical Instruments industry only one company had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 536 to 790.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 27.19 % 23.43 % -10.05 % -18.33 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 85 78 -75 -128 -121
Return On Equity (TTM) 17.64 % 17.29 % -17.59 % -29.31 % -26.19 %
LAB's Total Ranking # 790 # 536 # 2427 # 2528 # 2610
Equity (TTM) in Millions 540 561 424 400 425
Seq. Equity Change -3.77 % 32.25 % 6.16 % -5.86 % -6.61 %
Seq. Net Income Change - 558.96 % - - -

Back to LAB Management Effectiveness >> LAB's 5 Years Annual ROE >> Compare LAB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 2
Sector # 92
Overall # 790

Return On Equity Statistics
High Average Low
17.64 %
-153.52 %
-4329.61 %
(Jun 30 2026)   (Sep 30 2022)





LAB Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 424 472 -148 -81 95
Y / Y Equity Change -10.05 % - - - -31.97 %
Net Income in Millions -75 -139 -75 -190 -59
Y / Y Net Income Change - - - - -
Return On Equity -17.65 % -29.44 % - - -62.62 %

Back to LAB Management Effectiveness >> LAB's 5 Years Annual ROE >> Compare LAB ROE to its Competitors




More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LAB's' Return on Equity at Yahoo Finance
LAB's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LAB's Competitors
Subscribers only: Roe for Standard Biotools Inc 's Suppliers
Subscribers only: Return On Equity for LAB's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %

Date modified: 2026-09-01T20:00:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.